GO:0045109 intermediate filament organization: Cytoskeletal Assembly, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045109 intermediate filament organization is the biological process that controls the spatial distribution of intermediate filaments, including their assembly into meshworks, bundles, and cross-linked structures [1, 3].
• Intermediate filaments are dynamic cytoskeletal polymers whose organization is regulated by phosphorylation, cross-linking proteins, and developmental cues [2, 3, 6].
• Key genes include desmin, vimentin, keratins, neurofilament subunits, lamin A/C, and crescentin, each contributing to tissue-specific filament networks [1, 4, 5, 7].
• Disrupted intermediate filament organization is linked to neurodegeneration, muscular dystrophies, skin blistering diseases, and cancer progression [5, 6].
• CRISPR knockout, point-mutation knock-in, and overexpression models enable causal testing of intermediate filament genes in human cells and organoids [1, 2].
• Advanced imaging, proteomics, and CRISPR library screening are essential methods for dissecting intermediate filament organization and its disease relevance [1, 2, 4].
Description
Intermediate filament organization (GO:0045109) is a fundamental biological process that governs the spatial arrangement of intermediate filaments within cells, ensuring they form appropriate meshworks, bundles, or cross-linked structures [1, 3]. This process is critical for maintaining cell shape, mechanical integrity, and tissue-specific functions, and it is dynamically regulated during development, differentiation, and stress responses [2, 6]. Researchers study intermediate filament organization to understand how cytoskeletal architecture contributes to normal physiology and how its disruption leads to human disease [5, 7]. The QuickGO definition of GO:0045109 emphasizes control of the spatial distribution of intermediate filaments, including organizing filaments into meshworks, bundles, or other structures, as by cross-linking. This process is distinct from the mere presence of intermediate filament proteins; it specifically refers to their ordered assembly and positioning. Because intermediate filaments are encoded by a large gene family with tissue-specific expression, their organization is central to the functional specialization of different cell types [3, 7]. Understanding GO:0045109 therefore provides a framework for investigating cytoskeletal dynamics, cell mechanics, and disease mechanisms [2, 5].
intermediate filament organization At A Glance
| GO ID | GO:0045109 |
|---|---|
| GO term | intermediate filament organization |
| Ontology | biological_process |
| Synonym | intermediate filament organisation |
| Definition | Control of the spatial distribution of intermediate filaments; includes organizing filaments into meshworks, bundles, or other structures, as by cross-linking. |
| Major function | Spatial organization and remodeling of intermediate filament networks |
| Related cellular component | Intermediate filament cytoskeleton |
| Related molecular function | Structural constituent of cytoskeleton; cross-linking activity |
| Key regulatory mechanism | Phosphorylation and cross-linking by associated proteins |
What Is GO:0045109?
GO:0045109 intermediate filament organization is the biological process that controls the spatial distribution of intermediate filaments, including organizing filaments into meshworks, bundles, or other structures, as by cross-linking. In other words, it encompasses all cellular activities that determine where intermediate filaments are located, how they are arranged relative to each other, and how they are remodeled in response to cellular signals [3, 6].
Why Is intermediate filament organization Important in Cell Biology?
Intermediate filament organization is essential for maintaining cellular architecture, mechanical resilience, and tissue integrity, and its dysregulation is a hallmark of numerous human diseases, including neurodegeneration, muscular dystrophies, and cancer [2, 5, 6]. Because intermediate filaments are among the most stable cytoskeletal elements, their organization must be precisely controlled to allow dynamic cellular responses such as migration, division, and stress adaptation [1, 3]. Studying GO:0045109 therefore provides insights into fundamental cell biology and identifies therapeutic targets for diseases caused by cytoskeletal defects [5, 7].
• Maintains cell shape and mechanical stability in tissues subjected to mechanical stress [1, 2].
• Regulates organelle positioning and intracellular transport through filament networks [3, 6].
• Plays critical roles in neuronal development and function via neurofilament organization.
• Is essential for skin barrier function through keratin filament organization.
• Contributes to muscle integrity via desmin filament organization.
• Dysregulation is linked to cancer progression and metastasis [2, 5].
• Mutations in intermediate filament genes cause inherited diseases such as epidermolysis bullosa and cardiomyopathies [5, 6].
• Serves as a model for studying cytoskeletal dynamics and self-assembly [1, 4].
• Provides targets for CRISPR-based disease modeling and drug discovery [1, 2].
• Enables comparative studies of intermediate filament-like proteins in bacteria and metazoans.
What Happens During intermediate filament organization?
Filament assembly and nucleation
In simple terms: Intermediate filaments are built from protein subunits that come together to form long fibers.
Intermediate filament organization begins with the assembly of soluble subunit proteins into dimers, which then associate into tetramers and higher-order filaments [3, 7]. This process is driven by structural features of the central alpha-helical rod domain and is regulated by phosphorylation of the amino-terminal head domain. The resulting filaments serve as building blocks for more complex networks.
Meshwork and bundle formation
In simple terms: Filaments are arranged into networks or bundles to give cells shape and strength.
Once assembled, intermediate filaments are organized into meshworks or bundles through cross-linking by associated proteins and through interactions with other cytoskeletal elements [1, 2]. For example, desmin filaments form a three-dimensional meshwork in muscle cells, while keratin filaments bundle in epithelial cells [2, 7]. This organization is dynamic and can be remodeled during processes such as cell division and migration [3, 6].
Cross-linking and stabilization
In simple terms: Helper proteins connect filaments to each other and to other cell structures.
Cross-linking proteins such as plectin and filaggrin facilitate the organization of intermediate filaments into stable networks [2, 7]. These interactions are critical for maintaining tissue integrity and are regulated by signaling pathways that respond to mechanical stress and growth factors [1, 6]. Cross-linking also links intermediate filaments to desmosomes and hemidesmosomes in epithelial tissues.
Dynamic reorganization
In simple terms: Filament networks can be taken apart and rebuilt when cells need to change shape or divide.
Intermediate filament organization is not static; filaments undergo continuous reorganization during cell cycle progression, differentiation, and stress responses [3, 6]. Phosphorylation by kinases such as CDK1 and Rho-kinase triggers filament disassembly at mitosis, while phosphatases promote reassembly. This dynamic behavior is essential for processes like cytokinesis and cell migration.
Tissue-specific organization
In simple terms: Different tissues use different intermediate filament proteins to build specialized networks.
The organization of intermediate filaments is tailored to tissue-specific functions through the expression of distinct gene families [1, 5, 7]. Neurofilaments in axons are organized into parallel arrays that regulate axonal caliber, while keratins in skin form dense bundles that provide mechanical barrier function [5, 7]. This specialization is achieved by differential gene expression and post-translational modifications [3, 6].
Key Genes Involved in GO:0045109 intermediate filament organization
The following genes encode key intermediate filament proteins and associated factors that participate in intermediate filament organization (GO:0045109).
| Gene | Major Role | Research Relevance |
|---|---|---|
| KRT5 | Keratin 5, basal keratinocyte filament | Epidermolysis bullosa, skin models |
| KRT14 | Keratin 14, pairs with KRT5 | Epidermolysis bullosa, skin models |
| VIM | Vimentin, mesenchymal filament | Cancer, EMT, cell migration |
| DES | Desmin, muscle-specific filament | Cardiomyopathy, muscular dystrophy |
| GFAP | Glial fibrillary acidic protein, astrocyte filament | Neurodegeneration, astrocyte biology |
| NEFL | Neurofilament light chain | Axonal transport, neurodegeneration |
| NEFM | Neurofilament medium chain | Neurofilament assembly, ALS |
| NEFH | Neurofilament heavy chain | Axonal caliber, neurodegeneration |
| LMNA | Lamin A/C, nuclear intermediate filament | Laminopathies, nuclear organization |
| LMNB1 | Lamin B1, nuclear intermediate filament | Nuclear envelope stability |
| PLEC | Plectin, cross-linker of intermediate filaments | Epidermolysis bullosa, muscular dystrophy |
| FLG | Filaggrin, keratin filament aggregator | Ichthyosis vulgaris, atopic dermatitis |
| CRNN | Cornulin, epithelial differentiation | Squamous cell carcinoma |
| INA | Alpha-internexin, neuronal filament | Neurodevelopment |
| PRPH | Peripherin, peripheral neuron filament | Neurodegeneration |
| SYNM | Synemin, intermediate filament-associated protein | Muscle and astrocyte cytoskeleton |
| DSP | Desmoplakin, links filaments to desmosomes | Arrhythmogenic cardiomyopathy |
| JUP | Plakoglobin, desmosomal plaque protein | Cardiac and skin diseases |
How Is intermediate filament organization Regulated?
Intermediate filament organization is regulated by phosphorylation, which controls filament assembly and disassembly in a cell-cycle-dependent manner. Kinases such as CDK1 and Rho-kinase phosphorylate the head domains of intermediate filament proteins, promoting depolymerization during mitosis, while phosphatases reverse this process. Cross-linking proteins like plectin and filaggrin modulate network stability and are themselves regulated by signaling pathways [2, 7]. Additionally, mechanical stress and growth factor signaling can induce changes in intermediate filament organization through integrin-mediated pathways [1, 6].
intermediate filament organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KRT5 | Epidermolysis bullosa simplex | Knockout keratinocytes, skin organoids |
| DES | Desmin-related myopathy | Knock-in mouse, patient iPSC-derived cardiomyocytes |
| NEFL | Charcot-Marie-Tooth disease | Knockout motor neurons, neurofilament aggregation assays |
| LMNA | Dilated cardiomyopathy | Knock-in iPSC-derived cardiomyocytes |
| VIM | Cancer metastasis | Knockout cancer cell lines, xenograft models |
Neurodegenerative diseases
Disrupted organization of neurofilaments and glial fibrillary acidic protein (GFAP) is a hallmark of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. Abnormal accumulation and misorganization of neurofilaments impair axonal transport and contribute to neuronal death. Mutations in NEFL, NEFM, and NEFH have been linked to Charcot-Marie-Tooth disease and ALS.
Muscular dystrophies and cardiomyopathies
Mutations in DES (desmin) and PLEC (plectin) cause desmin-related myopathies and epidermolysis bullosa with muscular dystrophy, respectively, due to defective intermediate filament organization in muscle and skin. Desmin aggregates disrupt sarcomere function and lead to progressive muscle weakness. Similarly, lamin A/C mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy through altered nuclear intermediate filament organization.
Skin blistering diseases
Keratins KRT5 and KRT14 are essential for intermediate filament organization in basal keratinocytes, and mutations in these genes cause epidermolysis bullosa simplex, characterized by skin blistering upon mechanical stress. Filaggrin (FLG) mutations impair keratin filament aggregation and are associated with ichthyosis vulgaris and atopic dermatitis.
Cancer
Altered expression and organization of vimentin (VIM) and keratins are associated with epithelial-mesenchymal transition (EMT), tumor invasion, and metastasis. Vimentin filaments promote cell migration and are a marker of aggressive cancers. Targeting intermediate filament organization is being explored as a therapeutic strategy in oncology [1, 2].
From intermediate filament organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KRT5 disrupt keratin filament organization? | CRISPR knockout in HaCaT keratinocytes |
| How do DES mutations affect desmin assembly? | Point-mutation knock-in in C2C12 myoblasts |
| Can wild-type LMNA rescue nuclear envelope defects? | Knock-in of LMNA in LMNA-null iPSCs |
| Where is vimentin localized during EMT? | Tagged knock-in of VIM with GFP in cancer cells |
| Does NEFL overexpression alter neurofilament bundling? | Overexpression in primary neurons |
| What genes regulate intermediate filament organization? | CRISPR library screening in epithelial cells |
How to Study the intermediate filament organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Filament network morphology | Visualizing keratin or vimentin organization |
| Live-cell imaging | Dynamic filament reorganization | Tracking mitosis and migration |
| Mass spectrometry | Protein interactions and modifications | Identifying cross-linkers and kinases |
| CRISPR knockout screening | Gene requirement for filament organization | Discovering novel regulators |
| In vitro assembly assay | Filament polymerization kinetics | Testing mutant proteins |
| Immunoblotting | Protein expression and solubility | Assessing filament assembly state |
| Proximity ligation assay | In situ protein-protein interactions | Detecting cross-linking in cells |
| RNA-seq | Transcriptional changes | Profiling intermediate filament gene expression |
Fluorescence microscopy and live imaging
Fluorescence microscopy, including confocal and super-resolution techniques, is used to visualize intermediate filament organization in fixed and live cells [1, 4]. Tagged filaments (e.g., GFP-vimentin) allow dynamic tracking of network assembly and reorganization. Live imaging reveals filament dynamics during cell migration and division.
Proteomics and interactomics
Mass spectrometry-based proteomics identifies post-translational modifications and interacting partners of intermediate filament proteins. Affinity purification coupled to mass spectrometry can reveal cross-linking proteins and regulatory kinases. These approaches help define the molecular players in intermediate filament organization.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate intermediate filament organization [1, 2]. Such screens use readouts like filament morphology or stress resistance to uncover novel regulators. Bioinformatics analysis of screening data prioritizes candidate pathways for validation.
Biochemical assembly assays
In vitro assembly assays using purified intermediate filament proteins reconstitute filament formation and cross-linking [3, 7]. These assays measure kinetics of polymerization and the effects of mutations or post-translational modifications. They provide mechanistic insights into organization defects.
How CRISPR Can Be Used to Study GO:0045109 intermediate filament organization
Knockout
CRISPR knockout of intermediate filament genes such as KRT5, VIM, or DES allows researchers to assess their requirement for filament organization and cellular functions [1, 2]. Knockout cell lines can be used to test rescue by wild-type or mutant proteins. This approach is valuable for validating gene function in disease models.
Point Mutation
Point-mutation knock-in via CRISPR enables the study of disease-associated missense mutations in intermediate filament genes, such as those in DES or LMNA [1, 2]. These models reveal how specific amino acid changes affect filament assembly and organization. They are essential for understanding genotype-phenotype relationships.
Knock-in
Knock-in of tagged intermediate filament proteins (e.g., GFP-vimentin) using CRISPR allows real-time visualization of filament organization in live cells [1, 4]. This approach preserves endogenous regulation and enables dynamic studies. It can also be used to introduce reporter genes for screening.
Overexpression
CRISPR activation or cDNA overexpression of intermediate filament genes can model gain-of-function effects and filament aggregation, as seen in neurodegenerative diseases [5, 6]. Overexpression of NEFL or GFAP in neurons mimics pathological filament accumulation. This strategy helps dissect dosage effects on organization.
How EDITGENE Supports intermediate filament organization Research
Researchers studying intermediate filament organization-related genes often need to determine whether a candidate gene is causally involved in filament assembly, cross-linking, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies of GO:0045109.
Contact EDITGENE today to design your custom CRISPR model for intermediate filament organization research.
Frequently Asked Questions About intermediate filament organization
What is GO:0045109 intermediate filament organization?
GO:0045109 is the biological process that controls the spatial distribution of intermediate filaments, including organizing them into meshworks, bundles, or cross-linked structures.
What genes are involved in intermediate filament organization?
Key genes include KRT5, KRT14, VIM, DES, GFAP, NEFL, NEFM, NEFH, LMNA, PLEC, and FLG, among others [1, 2, 5, 7].
How is intermediate filament organization regulated?
It is regulated by phosphorylation, cross-linking proteins, and developmental signals that control filament assembly and disassembly [3, 6].
What diseases are linked to defective intermediate filament organization?
Diseases include epidermolysis bullosa, desmin-related myopathy, Charcot-Marie-Tooth disease, dilated cardiomyopathy, and cancer [2, 5, 7].
What methods are used to study intermediate filament organization?
Common methods include fluorescence microscopy, live imaging, proteomics, in vitro assembly assays, and CRISPR screening [1, 2, 3].
Can CRISPR be used to model intermediate filament diseases?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models are widely used to study disease mechanisms [1, 2, 5].
What is the role of vimentin in intermediate filament organization?
Vimentin forms dynamic filament networks in mesenchymal cells and is important for cell migration and EMT.
How do keratins contribute to intermediate filament organization?
Keratins KRT5 and KRT14 assemble into bundles that provide mechanical strength to skin keratinocytes.
What is the difference between intermediate filament organization and assembly?
Organization refers to the spatial arrangement of filaments into networks, while assembly is the stepwise polymerization of subunits [1, 3].
Why is intermediate filament organization important in neurons?
Neurofilament organization determines axonal caliber and transport, and its disruption leads to neurodegeneration.
Conclusion
Intermediate filament organization (GO:0045109) is a central biological process that governs cytoskeletal architecture and tissue-specific functions. Its dysregulation underlies a wide range of human diseases, making it a critical area of research [1, 5]. By leveraging CRISPR-based models and advanced imaging, researchers can dissect the molecular mechanisms of filament organization and identify new therapeutic targets [2, 3].
References
- 1. Coulombe PA. 2022. Capturing intermediate filament networks.. Elife 11 PMID: 35377313
- 2. Hohmann T et al.. 2019. The Cytoskeleton-A Complex Interacting Meshwork.. Cells 8(4) PMID: 31003495
- 3. Eriksson JE et al.. 1992. Intermediate filament dynamics.. Curr Opin Cell Biol 4(1):99-104 PMID: 1558758
- 4. Liu Y et al.. 2024. Filament structure and subcellular organization of the bacterial intermediate filament-like protein crescentin.. Proc Natl Acad Sci U S A 121(7):e2309984121 PMID: 38324567
- 5. Yuan A et al.. 2017. Neurofilaments and Neurofilament Proteins in Health and Disease.. Cold Spring Harb Perspect Biol 9(4) PMID: 28373358
- 6. Klymkowsky MW. 1995. Intermediate filament organization, reorganization, and function in the clawed frog Xenopus.. Curr Top Dev Biol 31:455-86 PMID: 8746673
- 7. Parry DA et al.. 1992. Intermediate filament structure.. Curr Opin Cell Biol 4(1):94-8 PMID: 1373068
